Alyson R Warr

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Topics

High Throughput

Multidrug Resistant

Top Venues

Journal of bacteriology

Antimicrobial agents and chemotherapy

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jacob E Lazarus, Alyson R Warr, Kathleen A Westervelt, David C Hooper, Matthew Kaden Waldor
A Genome-Scale Antibiotic Screen in Serratia marcescens Identifies YdgH as a Conserved Modifier of Cephalosporin and Detergent Susceptibility. Antimicrobial agents and chemotherapy 65 (12) (2021)
Alyson R Warr, Carole J Kuehl, Matthew Kaden Waldor
Shiga toxin remodels the intestinal epithelial transcriptional response to Enterohemorrhagic Escherichia coli. PLoS pathogens 17 (2) (2021)
Alyson R Warr, Rachel T Giorgio, Matthew Kaden Waldor
Genetic analysis of the role of the conserved inner membrane protein CvpA in EHEC resistance to deoxycholate. Journal of bacteriology (2020)
Alyson R Warr, Troy P Hubbard, Diana Munera, Carlos J Blondel, Pia Abel Zur Wiesch, Sören Abel, Xiaoxue Wang, Brigid M Davis, Matthew K Waldor
Transposon-insertion sequencing screens unveil requirements for EHEC growth and intestinal colonization. PLoS pathogens 15 (8) (2019)
Troy P Hubbard, Gabriel Billings, Tobias Dörr, Brandon Sit, Alyson R Warr, Carole J Kuehl, Minsik Kim, Fernanda D Young, John J Mekalanos, Joseph A Lewnard, Matthew Kaden Waldor
A live vaccine rapidly protects against cholera in an infant rabbit model. Science translational medicine 10 (445) (2019)